AGING/ELDERLY
Kendal Charitable Funds
Deadline: June 15, 2012 (LOI)
Funding: Up to $25,000
Purpose: To support new projects designed to enhance the lives of older adults, whether through services, research, and/or developing new understandings and awareness of the potential for aging well.
Eligibility: Grants are available only for new programs; existing programs are not eligible for funding.
Link: http://www.kendalcharitablefunds.org/
Go to Top
ALZHEIMER’S & RELATED DISORDERS
Alzheimer’s Drug Discovery Foundation, Charles River Discovery Research
Deadline: June 26, 2012 (LOI); July 10 (application)
Funding: Up to $150,000/1st year; possibility for 2nd year
Pupose: To accelerate discovery of new drugs for cognitive aging and Alzheimer’s disease, Alzheimer’s Drug Discovery Foundation (ADDF) has partnered with Charles River Discovery Research Services to co-develop and implement a grant program to fund pre-clinical studies focused on proof-of-concept testing of novel compounds in aged rats. For purposes of RFP, Charles River Discovery Research Services has made available aged rats up to 24 months old and relevant services.
Link: http://www.alzdiscovery.org/wp-content/uploads/2012/04/2012_charles-
river-addf-rfp_final2.pdf
Go to Top
Alzheimer’s Drug Discovery Foundation
Deadline: June 26, 2012 (LOI) July 10 (application)
Funding: Up to $150,000/1st year; possibility for 2nd year
Purpose: Drug Discovery, Early Detection, Clinical Trials, or Prevention.
Eligibility: Ph.D.., M.D., other professional.
Link: http://www.alzdiscovery.org/wp-content/uploads/2011/11/2012-general-rfp-and-funding-priorities1.pdf
Go to Top
The Association for Frontotemporal Degeneration (AFTD), Accelerating Drug Discovery for Frontotemporal Degeneration
Deadline: September 6, 2012 (LOI)
Funding: Up to $150,000
Purpose: AFTD provides support for basic and clinical research in frontotemporal degeneration and related clinical conditions (frontotemporal dementias, primary progressive aphasia, progressive supranuclear palsy and corticobasal syndrome). Priorities include:
• Development and testing of novel high throughput screening assays
• Medicinal chemistry on lead compounds
• Identification and in vitro testing of potentially disease modifying lead compounds
• ADME, toxicology, pharmacokinetics, pharmacodynamics on lead compounds
• Testing of lead compounds in a relevant animal model for preclinical proof of concept
• Development of biomarkers to accelerate drug development and early diagnosis
• Innovative pilot clinical trials
Link: http://www.theaftd.org/research/aftd-research-initiatives/current-rfps
Go to Top
ARTHRITIS
Arthritis Foundation, Clinical to Research Transitional Award
Deadline: August 1, 2012
Funding: Up to $60,000
Purpose: To support M.D.s who are clinically trained in adult or pediatric rheumatology and intend to pursue a research career in academic rheumatology.
Eligibility: Applicants must have an M.D. or equivalent degree. Candidates holding Ph.D. or M.D./Ph.D. degrees are not eligible, but those holding Masters degrees who meet the other requirements are eligible. US citizenship is not required but the applicant must hold a full-time appointment at a US institution.
Link: http://www.arthritis.org/research-funding-opportunities.php
Go to Top
Arthritis Foundation, Innovative Research Grant
Deadline: August 1, 2012
Funding: Up to $200,000 over 2 years
Purpose: To stimulate new approaches to solving arthritis, particularly in Rheumatoid Arthritis (RA), Osteoarthritis (OA), and Juvenile Arthritis (JA). The program supports basic and clinical research of independent investigators.
Eligibility: Individuals with doctoral degrees (M.D., Ph.D., or equivalent) at the assistant professor level or higher. Multi-institutional collaborations are encouraged. Multi-institutional proposals may include collaborators from outside the United Sates but the lead institution must be based in the USA. Principal investigator must be a US citizen or permanent resident at the time of application.
Link: http://www.arthritis.org/research-funding-opportunities.php
Go to Top
AUTOIMMUNE DISEASES
The National Multiple Sclerosis Society, Pilot Research Grants
Deadline: New applications accepted on ongoing basis.
Funding: Max of $40,000 in direct costs for 1 yr, plus 10% indirect costs
Purpose: High-risk pilot grants to test novel ideas. Funding is provided for one year to test innovative ideas or untested methods and gather sufficient preliminary data to apply for longer-term funding. Supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation.
Eligibility: Person indicated as PI in an application is personally and actively responsible for conduct of research and considered eligible by his or her institution to apply for a research grant. Applications for Pilot Research Projects under the direction of postdoctoral fellows or for graduate students will not be accepted. Pilot awards may not support dissertation work for a graduate student. Postdoctoral fellows are encouraged to apply for one of the Society's programs of research training.
Link: http://www.nationalmssociety.org/for-professionals/researchers/get-funding/pilot-research-grants/index.aspx
Go to Top
BASIC & BIOMEDICAL RESEARCH
Whitney Foundation, Helen Hay, Postdoctoral Research Fellowships
Deadline: July 16, 2012
Funding: $147,000 across 3 years, contingent on satisfactory performance: $48,000 year 1, $49,000 year 2, $50,000 year 3. Research allowance of $2,500/year. Dependent child allowance $1,000/year per child.
Purpose: To support early postdoctoral research training in all basic biomedical sciences. The foundation grants financial support to help further the careers of people engaged in biological or medical research.
Eligibility: Candidates who hold, or are in the final stages of obtaining, Ph.D., M.D., or equivalent degree and are seeking beginning postdoctoral training in basic biomedical research are eligible to apply for a fellowship. The foundation accepts applications from candidates who have no more than 1 year of postdoctoral research experience at the time of the deadline for submitting the application (July 16) and who have received a Ph.D. or equivalent no more than 2 years before the deadline, or an M.D. no more than 3 years before deadline.
Link: http://www.hhwf.org/HTMLSrc/ResearchFellowships.html
Go to Top
BIRTH DEFECTS AND INHERITED DISEASE RESEARCH
Cystic Fibrosis Foundation, Clinical Research Awards
Deadline: June 1, 2012 (Letter of Intent)
Funding: $300,000 to $675,000. Up to $100,000/year for up to 3 years for single-center clinical research grants. For multi-center clinical research, up to $225,000/year up to 3 years.
Purpose: Support to clinical research projects directly related to Cystic Fibrosis (CF) treatment and care. Projects may address diagnostic or therapeutic methods related to CF or the pathophysiology of CF. Applicants must demonstrate access to a sufficient number of CF patients from accredited CF Foundation care centers and appropriate controls.
Eligibility: Ph.D., M.D., other professional. Citizenship or Residency Unrestricted. Applicants must demonstrate access to a sufficient number of CF patients from foundation-accredited care centers and appropriate controls.
Link: http://www.cff.org/research/ForResearchers/FundingOpportunities/
ClinicalResearchAwards/
Go to Top
Cystic Fibrosis Foundation Therapeutics, Inc.
Deadline: June 1, 2012 by 5:00 p.m. (LOI)
Funding: Up to $100,000 for up to 3 years
Purpose: To support projects designed to answer questions about the pathophysiology of CF or its management, or pilot programs aimed at determining the best strategies and methods for approaching questions that require assessment through larger-scale research and/or multi-center, collaborative trials.
Eligibility: Applicants must describe fully the potential impact of the proposed project on the pathological consequences of Cystic Fibrosis.
Link: http://www.cff.org/research/
Go to Top
Hereditary Disease Foundation
Deadline: continuous (LOI)
Funding: Up to $50,000
Purpose: The focus of the Hereditary Disease Foundation is on Huntington's disease. Support research projects that will contribute to identifying and understanding the basic defect in Huntington's disease. Areas of interest include trinucleotide expansions, animal models, gene therapy, neurobiology and development of the basal ganglia, cell survival and death, and intercellular signaling in striatal neurons.
Link: http://www.hdfoundation.org/funding/grants.php
Go to Top
National Marfan Foundation
Deadline: June 11, 2012
Funding: Up to $50,000 for 1 year
Purpose: To support research related to the Marfan syndrome and related connective tissue disorders. The goal of this program is to advance research in this area and to identify methods for earlier diagnosis, improved therapies and to find an eventual cure.
Eligibility: The principal investigator must hold an M.D., D.O., Ph.D. or equivalent degree. The investigator must have proven ability to pursue independent research as evidenced by original research publications in peer-reviewed journals.
Link: http://www.marfan.org/marfan/2293/Research-Grants
Go to Top
CANCER RESEARCH
Damon Runyon Cancer Research Foundation - Postdoctoral Fellowship Awards
Deadline: August 15, 2012
Funding: Level 1 up to $156,000 over 3 years; Level 2 up to $186,000 over 3 years.
Purpose: To support exceptional early career researchers pursuing innovative cancer research having the potential to significantly impact understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Foundation's mission is to identify and support researchers who are committed to discovery leading to new understanding of the cell and how it becomes cancerous, as well as innovative approaches to the prevention, early diagnosis and treatment of all forms of the disease.
Eligibility: Applicants must hold M.D., M.D. / Ph.D., Ph.D., or equivalent degree; identify a faculty mentor with whom a research plan will be developed, executed and supervise; and have not already accepted a postdoctoral research fellowship award.
- Level 1: Basic and physician-scientists must have received degrees on or after Oct 15, 2010; began in sponsor's labs after Oct 15, 2010; and devote 100% of time to Damon Runyon-supported research activities.
- Level 2: Physician-scientist applicants must have completed residencies and clinical training on or after Oct 15, 2008; must be board eligible at start date of Fellowship, and able to devote at least 80% of time to Damon Runyon-supported research activities.
Link: http://www.damonrunyon.org/for_scientists/more/fellowship_award_
application_guidelines
Go to Top
Damon Runyon Cancer Research Foundation
Deadline: June 1, 2012 (pre-proposal)
Funding: $450,000 over three years
Purpose: The Damon Runyon-Rachleff Innovation Award provides support for the next generation of creative thinkers with “high risk/high reward” ideas that can impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.
Eligibility: Institutional nominations not required; no limit to the number of applications that can be received from a particular institution. Applicants must be conducting independent research. Applicants must be tenure-track Assistant Professors within the first three years of obtaining their initial Assistant Professor position; Clinical Instructors and Senior Clinical Fellows holding an M.D. who are pursuing a period of independent research before taking a tenure-track faculty position; or Distinguished Fellows with a record of research accomplishments.
Link: http://www.damonrunyon.org/for_scientists/more/innovation_award_overview
Go to Top
National Brain Tumor Society, Innovation Research Grant
Deadline: Letter of Intent accepted on a rolling basis. Submit by June 17 for next review.
Funding: $300,000 ($150,000 per year for 2 years.) No Indirect Costs.
Purpose: For transformative or catalytic scientific research projects that will significantly move the field forward toward effective brain tumor therapies. Will fund projects that highlight innovative research strategies and will support the development of novel brain tumor therapies for adult and/or pediatric brain tumor patients.
Eligibility: Ph.D., M.D., other professional. Citizenship or Residency Unrestricted. Open to all levels of scientists.
Link: http://www.braintumor.org/research/funding-opportunities/
Go to Top
W. W. Smith Charitable Trust, Medical Research Award (NOTE: CANCER OR AIDS)
Deadline: June 15, 2012 (proposal)
Funding: $150,000
Purpose: The Trust continues to fund basic medical research in the areas of Heart, Cancer and AIDS and highlights the importance of basic medical research in the area of Juvenile Diabetes and continues to provide funds for finding a cure. The Trust tries to select promising researchers who have the potential to attract the NIH or other large funding organizations after the Trust’s support. Grants have generally been for basic medical research for faculty with appointments in universities, hospitals and research centers in the Delaware Valley.
Eligibility: Ph.D.., M.D., other professional.
Link: http://www.wwsmithcharitabletrust.org/guidelines.htm (SEE FCR OFFICE)
Go to Top
The Multiple Myeloma Research Foundation
Deadline: June 30, 2012
Funding: Up to $1,500,000 (including direct and indirect costs)
Purpose: To identify and understand the impact of various epigenetic modifications of DNA and histones in the initiation, progression, and treatment of myeloma utilizing state of the art technologies.
Eligibility: Must be a collaborative, multi-institutional program (at least 2 separate research institutions) consisting of a maximum of 3 major research aims that will lead to a better understanding of the role of epigenetics in myeloma disease biology and treatment.
Link: http://www.themmrf.org/assets/research-programs/2012-epigenetics-rfa.pdf
Go to Top
Uniting Against Lung Cancer
Deadline: August 15, 2012 (full proposal)
Funding: Up to $100,000 (across 2 years)
Purpose: To jumpstart new projects leading to improved treatments and a cure for lung cancer, including non-small cell and small cell lung cancer. Must have a clear hypothesis and research plan to be completed within 2 year grant term. Areas of interest include, but are not limited to, the following:
- Developing novel therapies with potential to cure lung cancers
- Genetic subsets of lung cancer / personalized medicine
- Primary and secondary drug sensitivity/resistance
- Lung cancer in never-smokers
- Improving outcomes in early stage disease
- Small cell lung cancer
Eligibility: Investigators at all levels, including Postdoctoral and Clinical Fellows, will be funded through the Legacy Program and are encouraged to apply. In addition to funding the highest quality science, we have prioritized providing start-up funds for early-career investigators to build the foundation for a lung cancer research program. Collaborations with industry partners are also strongly encouraged; however the Principal Investigator is required to be an academic researcher.
Link: https://www.grantinterface.com/UALC/Common/LogOn.aspx
Go to Top
DIABETES
American Diabetes Association Development Awards
Deadline: July 15, 2012
Funding: For Junior Faculty Awards, $120,000 per year for three years; for Career Development Awards, $150,000 per year for five years
Purpose: Junior Faculty Awards support new investigators who are establishing their independence in diabetes research. Applicants can have any level of faculty appointment up through assistant professor. Career Development Awards are designed to assist outstanding Assistant Professor level faculty investigators in conducting diabetes-related research. The award supports an individual's salary and research project to enable the investigator to advance his/her career as an independent investigator.
Link: http://professional.diabetes.org/Diabetes_Research.aspx?cid=64382#CD_Award
Go to Top
American Diabetes Association General Research Awards
Deadline: July 15, 2012
Funding: For Basic Science Awards, $115,000 per year for three years; for Clinical/Translational Awards, $200,000 per year for three years
Purpose: Basic Science Awards provide grant support to both new and established investigators; applications will be considered in any area that is relevant to the etiology or pathophysiology of diabetes and its complications. Clinical/Translational Awards are designed to support patient-oriented research in diabetes. For the purpose of this award, clinical research is defined as research directly involving humans, and includes educational, psychosocial, behavioral, epidemiologic, and health services research; also studies of normal physiology and mechanisms of disease.
Link: http://professional.diabetes.org/Diabetes_Research.aspx?typ=18&cid=64381
Go to Top
Juvenile Diabetes Research Foundation (JDRF)
Deadline: July 16, 2012
Funding: Up to $150,000
Purpose: To attract qualified and promising scientists early in their faculty careers and to give them the opportunity to establish themselves in areas that reflect the JDRF research emphasis areas
Eligibility: Applicant must have M.D., Ph.D., or equivalent and faculty position or equivalent.
Link: http://www.jdrf.org/index.cfm?page_id=114014
Go to Top
Novo Nordisk Diabetes Innovation Award Program - Early Exploration Award
Deadline: August 1, 2012
Funding: Up to $250,000 over 2 years, plus indirect costs.
Purpose: Supports new and established scientists in exploration of novel hypotheses in diabetes and obesity research. Aim of research award program is to help scientists substantiate early innovation research efforts and clarify if their hypotheses could result in new treatment options for diabetes and obesity.
Eligibility: Must hold full-time faculty positions or the equivalent at accredited university-affiliated institutions or equivalent. pplicants must hold a Ph.D., M.D., Pharm.D. degree or equivalent health, science or engineering related degree. Application must not contain any confidential information.
Link: http://www.novonordisk-us.com/documents/article_page/document/diabetes_
innovation_awards.asp
Go to Top
Novo Nordisk - Innovation Award Program: Proof of Principle Award
Deadline: August 1, 2012 by 8:00 p.m.
Funding: Up to $500,000 over two years, plus indirect costs.
Purpose: To support nonclinical research for validation of early-stage innovations in treatment of diabetes or obesity with sufficient supporting data to conclude on nonclinical proof of principle (PoP) studies. Aim of Novo Nordisk Diabetes Innovation Award Program is to help scientists substantiate early research efforts and clarify whether hypotheses could result in new treatment options for diabetes and obesity.
Types of research eligible for support:
- New biological targets amenable to protein-based therapeutics;
- Research exploring novel protein effects and functions; and
- Protein-based science technologies including oral and injection delivery concepts.
Eligibility: Full-time faculty and hold a Ph.D., M.D., Pharm.D. degree or equivalent. Must be citizens or permanent residents. May not receive funding from any other source for the proposed research or related research.
Link: http://www.novonordisk-us.com/documents/article_page/document/
diabetes_innovation_awards_<
how_to_apply.asp
Go to Top
GENETIC DISEASES
Jain Foundation (for LGMD2B/Miyoshi Research)
Deadline: Researchers are welcome to contact the the foundation with a pre-proposal at any time. Typically the foundation responds to grant submissions within 4-6 weeks.
Funding: $50,000 to $150,000 and up.
Purpose: The explicit goal of the Jain Foundation is to expedite development of a treatment or cure for LGMD2B/Miyoshi. LGMD2B and Miyoshi are both caused by inherited genetic mutations in the gene for dysferlin. The project must have direct relevance to dysferlin deficiencies - either to extend understanding of the disease or a unique approach to a treatment for the disease. Project should not have been performed elsewhere and sufficient due diligence should have been executed to find out if the same project is currently being studied in another lab.
Eligibility: Ph.D.., M.D., other professional.
Link: https://www.jain-foundation.org/index.php
Go to Top
The LAM Foundation
Deadline: July 30, 2012
Funding: $150,000 over 3 years
Purpose: To support projects that focus on the genetic regulation of smooth muscle growth or the development of a smooth muscle cell line that is representative of the LAM lesion.
Eligibility: Scientists who wish to apply for LAM research funding must submit a Letter of Intent (LOI). LOIs are reviewed by the Scientific Advisory Board (SAB) for scientific merit and alignment with The LAM Foundation mission. SAB invitations to submit full proposals are extended to applicants whose LOI proposals are considered competitive, but invitations are not a prerequisite for submission.
Link: http://www.thelamfoundation.org/research/apply-for-lam-funding
Go to Top
HEALTH CARE
The American Society for Healthcare Risk Management
Deadline: June 15, 2012
Funding: Up to $100,000
Purpose: To stimulate research on healthcare risk management issues and supports research projects that are either quantitative or qualitative in nature.
Eligibility: Research proposals that are of interest to healthcare risk managers and/or patient safety professionals; align with ASHRM’s vision and mission statement; and involve outcomes research, practice guidelines establishment or demonstration projects are particularly encouraged.
Link: http://www.ashrm.org/ashrm/education/development/research/index.shtml
Go to Top
HEART DISEASE
American Heart Association - Summer 2012 National Innovative Research Grant*
Deadline: July 17, 2012
Funding: Up to $150,000 over two years (includes 10% indirect costs)
Purpose: To support highly innovative, high-risk, high-reward research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and stroke research
Eligibility: Applicants must hold an M.D, Ph.D. or equivalent doctoral degree. At the time of award activation, applicants must have a faculty (or faculty equivalent) appointment. See announcement for citizenship requirements
Link: http://my.americanheart.org/professional/Research/FundingOpportunities/
Funding-Opportunities_UCM_316909_SubHomePage.jsp
Go to Top
American Heart Association - Summer 2012 National Clinical Research Program*
Deadline: July 17, 2012
Funding: Up to $154,000 over 2 years (includes 10% indirect costs)
Purpose: To support early career investigators who have appropriate and supportive mentoring relationships to engage in high quality introductory and pilot clinical studies that will guide future strategies for reducing cardiovascular disease and stroke.
Eligibility: Applicants must be healthcare professionals with a masters or post-baccalaureate doctoral degree, including MPH, R.N, M.D., Ph.D. Interdisciplinary research teams are eligible. See announcement for citizenship requirements
Link: http://my.americanheart.org/professional/Research/FundingOpportunities/
Funding-Opportunities_UCM_316909_SubHomePage.jsp
Go to Top
American Heart Association - Summer 2012 National Scientist Development Grant*
Deadline: July 17, 2012
Funding: Up to $308,000 over 4 years (includes 10% indirect costs)
Purpose: To support early-career scientists in their progress toward independence by encouraging and adequately funding research projects that can bridge the gap between completion of research training and readiness for successful competition as an independent investigator
Eligibility: Must hold M.D., Ph.D. or equivalent post-baccalaureate doctoral degree. At time of award, applicants must hold faculty/staff position up to/including the rank of assistant professor (or equivalent). No more than 4 years since an applicant's first faculty/staff appointment (after receipt of doctoral degree) at the assistant professor level or its equivalent. See announcement for citizenship requirements
Link: http://my.americanheart.org/professional/Research/FundingOpportunities/
Funding-Opportunities_UCM_316909_SubHomePage.jsp
Go to Top
American Heart Association - Summer 2012 National Established Investigator Award*
Deadline: July 17, 2012
Funding: Up to $400,000 over 5 years (includes 10% indirect costs)
Purpose: To support mid-career investigators with an established record of accomplishments; candidates must have a demonstrated commitment to cardiovascular or cerebrovascular science as indicated by prior publication history and scientific accomplishments.
Eligibility: Must have an M.D., Ph.D. or equivalent and be faculty/staff member; must also have current national-level funding as PI (or co-PI) on an R01 grant or its equivalent (e.g. VA Merit Award, NSF Grant, or PI of a project on a Program Project Grant from NIH). At time of award, must have at least 4 years but no more than 9 years since first faculty/staff appointment at assistant professor level or equivalent.
Link: http://my.americanheart.org/professional/Research/FundingOpportunities/
Funding-Opportunities_UCM_316909_SubHomePage.jsp
Go to Top
Children's Cardiomyopathy Foundation - Research Awards
Deadline: September 2, 2012
Funding: Up to $50,000 across 1 year.
Purpose: To support innovative basic, clinical, or translational studies relevant to the cause or treatment of cardiomyopathy in children under the age of 18 years. Provides seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding from other sources. CCF expects to make award decisions by January 2013.
Eligibility: M.D., Ph.D., or equivalent; faculty appointment, and proven ability to pursue independent research as evidenced in publications in peer-reviewed journals.
Link: http://www.childrenscardiomyopathy.org/site/grants.php
Go to Top
Medtronic Foundation, HeartRescue Grant Program
Deadline: LOI (accepted continuously)
Funding: $90,000 over 3 years max.
Purpose: The goal of the HeartRescue program in the United States is to have a long-term impact in communities by creating a new generation of people who will understand the risk factors for sudden cardiac arrest (SCA), will recognize SCA when it happens, and take immediate action to help save a life when it does.. Priority given to new initiatives that have no prior funding for their project. Priority also given to applicants who best demonstrate sustainability, cost effectiveness, community partnerships, and those that include a component serving a socio-economically disadvantaged or minority population.
Eligibility: Priority will be given to schools, school districts, nonprofit organizations, and government agencies that develop or improve existing components of a comprehensive school-based SCA education and emergency response plan.
Link: http://www.medtronic.com/foundation/grants/heart-rescue.html
Go to Top
IMMUNOLOGY
BD Biosciences Immunology Research Grants
Deadline: August 31, 2012
Funding: Up to $140,000
Purpose: To support innovation in research and development in order to define the next generation of scientific breakthroughs. Research areas include: multicolor flow cytometry; cell signaling; cancer research; immune function; infectious diseases; and neuroscience research.
Eligibility: Ph.D., M.D., or other professional. Only one grant application will be accepted per laboratory.
Link: http://www.bdbiosciences.com/research/grant/apply/immuno.jsp
Go to Top
LUPUS RESEARCH
Alliance for Lupus Research
Deadline: July 2, 2012
Funding: Up to $600,000 over 3 years
Purpose: To support research projects that are relevant to basic, translational or clinical investigation in lupus.
Eligibility: Applicants must have a doctoral degree (M.D., Ph.D., or equivalent). The ALR funds research that will accelerate the development of new treatments for lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques.
Link: http://www.lupusresearch.org/research/grants.html
Go to Top
MEDICAL EDUCATION ASSESSMENT
Edward J. Stemmler, M.D. Medical Education Research Fund, National Board of Medical Examiners (NBME)
Deadline: Jul 02, 2012 (LOI); Jan 14, 2013 (Full Proposal)
Funding: $150,000 for up to 2 years
Purpose: For research/development of innovative evaluation methodology or techniques, with potential to advance assessment in medical education or practice at eligible medical schools. Expected outcomes include advances in the theory, knowledge, or practice of assessment at any point along the continuum of medical education, from undergraduate and graduate education and training, through practice. Collaborative investigations within or among institutions are eligible.
Eligibility: Medical schools accredited by the LCME or the AOA. Additional eligibility requirements include: unlimited submissions for medical schools, but an individual may not be PI on more than 1 LOI. Designated PI must represent the primary applicant institution and must be responsible for project oversight and reporting. Applications addressing the same substantive study topic by the same investigators may be submitted for Fund consideration no more than 3 times.
Link: http://www.nbme.org/research/stemmler.html
Go to Top
MUSCULAR DYSTROPHY
Muscular Dystrophy Association - MDA Research Grant & MDA Development Grant
Deadline: June 15, 2012 (Letter of Intent); July 15, 2012 (Full Application)
Funding: Research Grant, Unlimited amount, 1 to 3 years; Development Grant, Up to $180,000, 1 to 3 yrs.
Purpose: To support research aimed at developing treatments for the muscular dystrophies and related diseases of the neuromuscular system
Eligibility: Research Grant. Must be independent investigators and hold an M.D., Ph.D., D.Sc or equivalent. Must be professional or faculty member (Professor, Associate Professor, or Assistant Professor) at an educational, medical or research institution. Applicants must be qualified to conduct and mentor a program of original research. Development Grant, must hold an M.D., Ph.D., D.Sc. or equivalent and be member of research team. Must be qualified to conduct program of original research under supervision of PI.
Link: http://www.mdausa.org/research/guidelines.html
Go to Top
Muscular Dystrophy Association- Clinical Research Training Grant
Deadline: August 15, 2012
Funding: $90,000 per year for 2 years
Purpose: to provide promising young clinicians with the research training opportunities needed to become productive clinical investigators in neuromuscular disease research. This training opportunity is designed to be compatible with the requirements of a traditional clinical fellowship in neuromuscular disease and any forthcoming requirements for certification in neuromuscular disease.
Eligibility: must hold a Doctor of Medicine or Doctor of Osteopathy degree and be licensed to practice medicine in the state or province in which the grant will be given; be board eligible or board certified in neurology, child neurology or physical medicine and rehabilitation at the time of the award.
Link: http://www.mdausa.org/research/trac/trac_grant_clirestraining.html
Go to Top
MUSCULOSKELATAL SYSTEM
AO Foundation Start-up Grant Program
Deadline: July 15, 2012
Funding: Up to 60,000 CHF (approximately 65,345 USD)
Purpose: To support international advancement in the surgical treatment of trauma and degenerative disorders of the musculoskeletal system through research, development and education.
Eligibility: Young investigators who are within five years of the completion of his/her terminal degree (M.D., D.V.M., Ph.D., etc.) or within five years of initiation of his/her first assistant professor position at an academic institution.
Link: https://www.aofoundation.org/Structure/research/research-funding/
Pages/aorf-application-report-form.aspx
Go to Top
OBESITY
Robert Wood Johnson Foundation, Healthy Eating Research
Deadline: August 9, 2012
Funding: Up to $100,000
Purpose: To fund and communicate strategic and timely research addressing key evidence needed to advance RWJF's policy priorities — providing advocates, decision-makers, and policy-makers with innovative, solution-oriented, policy-relevant environmental and policy studies to guide policy action.
Eligibility:
Link:
Go to Top
PARKINSON’S DISEASE
The Michael J. Fox Foundation for Parkinson's Research
Deadline: June 1, 2011 (pre-proposal)
Funding: $250,000 over 2 years
Purpose: The Edmond J. Safra Core Programs for PD Research, part of the Foundation's annual Pipeline Programs, is a series of three funding opportunities that seek investigator-initiated proposals. The Foundation is currently accepting applications for the Target Validation program, which supports work demonstrating whether modulation of a novel biological target has impact in a PD-relevant animal model – an essential early step to the development of potential targeted therapies.
Eligibility: Post-doctoral fellows are NOT eligible to apply as PIs for Target Validation projects.
Link: http://www.michaeljfox.org/research_openFundingPrograms_program.cfm?ID=12
Go to Top
PEDIATRIC AND FAMILY HEALTH
The Gerber Foundation
Deadline: June 1, 2012
Funding: Up to $300,000
Purpose: To fund research projects aimed at finding solutions to children’s health and nutritional problems. Of particular interest are those offering meaningful advances in prevention and treatment of diseases and those with broad applicability to the general population.
Link: http://www.gerberfoundation.org/
Go to Top
Maternal, Newborn, and Child Health Grants (Global Health), Bill and Melinda Gates Foundation
Deadline: LOIs accepted continuously
Funding: $200,000 to $5,000,000
Purpose: The foundation is currently developing the following strategies, which it believes will have the greatest potential to save the lives of mothers and children in the developing world:
1. Improve care during pregnancy and delivery.
2. Improve newborn care.
3. Improve health care for children under two years of age.
4. Research, document, and promote the effects of the work.
5. Advocate for more attention to the health of women, babies, and children.
Eligibility: Non-profits.
Link: http://www.gatesfoundation.org/grantseeker/Pages/funding-maternal-newborn-child-health.aspx
Go to Top
SLEEP RESEARCH
American Sleep Medicine Foundation, Strategic Research Award.
Deadline: August 15, 2012
Amount: Up to two one-year grants of $75,000
Purpose: Planning grants or research grants for efforts to improve quality of healthcare delivery in the sleep medicine field. Urgent need for 1) identifying a better framework for healthcare delivery in the field of sleep medicine such as the patient-centered home model; 2) establishing or enhancing patient registries that help healthcare providers better monitor and deliver healthcare while assisting outcomes research; and 3) developing new patient-outcome measures or better validating existing measures to assist healthcare delivery and policymaking.
Eligibility: Physicians (M.D., DO) and Ph.D.s. A physician or scientist who is an active AASM member should be affiliated with project. Competitive application should have significant input from health services researchers and/or biostatisticians in conception/design of proposal or planning grant. The role of the sleep physician/scientist should be clearly defined in the project’s scope.
Link: http://www.discoversleep.org/researchaward.aspx
Go to Top
SPINAL RESEARCH
International Spinal Research Trust
Deadline: Jun 08, 2012, Letter of Intent
Funding: Support for a post-doctoral salary plus laboratory consumables for up to 3 years. Funding also available for equipment where justified and essential for project objectives.
Purpose: To develop reliable treatments for paralysis caused by a broken back or neck. RFP for proposals that address or help identify clinically relevant effective treatments in either severe or chronic spinal cord injuries. Proposals that address both criteria are especially welcomed.
Eligibility: New Faculty/New Investigator; Ph.D./M.D./other professional
Notes: See themes identified by the Scientific Advisory Committee: research strategy discussion document. Preference will be given to applications that involve studies in the adult mammalian spinal cord.
Link: http://www.spinal-research.org/research-matters/grants-awards/applying-for-a-grant/types-of-grant/
Go to Top
SURGERY
American Surgical Association Foundation (ASAF) Fellowship
Deadline: June 15, 2012 Full Proposal
Funding: $75,000 per year, renewable
Purpose: To support and encourage young surgeons who choose careers in investigation and academic surgery. During the fellowship years, the awardee should have a primary role in research and teaching. The fellow should have a faculty position following the fellowship in the department of surgery of the sponsoring institution.
Eligibility: Ph.D.., M.D., other professional. The applicant must have completed an ACGME-approved residency in general surgery or a surgical specialty and hold a faculty appointment in an accredited medical school or a similar medical institution. The application for the fellowship must be submitted within five years from the time that the applicant has completed their residency. Acceptance of other career development or fellowship awards precludes application for the ASAF Fellowship.
Link: http://www.americansurgical.info/awards_Fellowship.cgi
Go to Top
Oral and Maxillofacial Surgery Foundation
Deadline: July 15, 2012
Funding: $12,500 (Student Research Training) to $75,000 (Research Support); $55,000, (Zimmer/Implantology)
Purpose: Student Research Training Awards are meant to attract high quality health profession students to biomedical and behavioral research applicable to oral and maxillofacial surgery. Research Training Grants further the development of experienced scientific investigators who are committed to problems related to oral and maxillofacial surgery, and encourage promising lines of research and clinical investigation. The Zimmer Award offers $55,000 to an experienced investigator whose research is focused on implantology.
Eligibility: The eligibility requirements for the Research Support Grant allow a non-OMS (Oral-Maxillofacial Surgeon) to serve as the principal investigator as long as the co-principal investigator is a qualified OMS in an active role.
Link: http://www.omsfoundation.org/Page.aspx?pid=349#pida
Go to Top
VACCINE DEVELOPMENT
Bill and Melinda Gates Foundation, 2012 Gates Vaccine Innovation Award
Deadline: August 31, 2012 (Nominations due)
Funding: $250,000
Purpose: To support applicants who have achieved significant improvements in prevention, control, or elimination of vaccine preventable diseases through immunization. Nominees will be assessed on three broad criteria: Developing country impact , Innovation and Creativity; and Scale.
Eligibility: Candidates from academic institutions, governments, healthcare facilities, research institutions, non-profit organizations and for-profit companies may be nominated
Link: http://www.gatesfoundation.org/vaccines/Pages/vaccine-innovation-award.aspx
Go to Top
